GNRH1 and adenomyosis: The rationale for using GnRH analogues for the medical treatment of adenomyosis is the direct antiproliferative effect within the myometrium through actions on the GnRH receptors expressed by adenomyotic lesions with a systemic and local hypoestrogenic effect through a central downregulation and a profound suppression of gonadotropin secretion.